FGFR1/PI3K/AKT signaling pathway is a novel target for antiangiogenic effects of the cancer drug fumagillin (TNP-470) (Q79762065)
Jump to navigation
Jump to search
scientific article published on 01 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FGFR1/PI3K/AKT signaling pathway is a novel target for antiangiogenic effects of the cancer drug fumagillin (TNP-470) |
scientific article published on 01 August 2007 |
Statements
FGFR1/PI3K/AKT signaling pathway is a novel target for antiangiogenic effects of the cancer drug fumagillin (TNP-470) (English)
Gregory J Chen
Brian Weylie
Chen Hu
James Zhu
Reza Forough
1 August 2007